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Pharmacologic Perturbation of Neutraphils by Fluosol
Results in a Sustained Reduction in Infarct Size in the Canine
Model of Reperfuslon
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HARRY D. VILDIBILL, BS, THOMAS L. LAMBERT, MD, DAVID A . INGRAM, BS,
RENU VIRMANI, MD, FACC . - JOHN J. MURRAY, MD, PHD
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Tennessee and WRSIrirrer,m, D.C .
Previous studies have drmomtrated that inravenous administra-
lion of large doses of Flaosel, a perfuarodtetnleal preparation,
reduced infarct sire 24 h alter reperfusan, as effect that was
associated with reduced neutrophil ilhhltralion . The effect of a
clinically tolerable dose of Flaosol a Infarct six after a prolonged
period of reperfmMo and its mechankm of action on neurophlls
remain unknown.
Twenty-one aosthdized dosed chest dogs were subjoeted to
90 adh of proximal left anterior descending coronary artery
occlusion and 72 h of reperfusion. An additional five dogs that did
not undergo regional Imouxrdral ischrmia wrre utilized to eaplure
die mechanism of anion of Plaited so neutraphit function
. In the
id-et study, auimale were raodaolred to receive either id-e.
nuns Flavserl In = IN
or an equivalent volune or Ringer's lactate
5011dioe (control; n = I U al 15 mhkg body weight during the last
30 min of ordmion and for the 1st 34 min of repedstsioe .
Fluaseti aignlncathy reduced infarct sin when expressed as
peeved area d risk 72 h aver reperfosion 113-7 s 2
.7% on
. 3a3
t 4.5%, rspardvdr
. p
- 0.0011. This reduction was associated
with significant improvement in regional waft nldion (18.4 ±
2.3% vs. 5.5 t 2%, p -,
0.001). Endocardial blood h o'c in the
Isehemk bed was dgniOcantly higher 3 h after reperfusion let
Polymorphonuetear Icakocyles (neulrophils) play an impor-
tant role in the acute inflammatory response aftermyocardiat
ischemia (I) .
Peak accumulation of neutrophils in the setting
of permanent coronary occlusion occurs after 12 to 24 h and
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Fluosol-treated dogs (0
.63 t 0.48 vs. 0.34 t 0 .07 mVmin per g,
p = 0.01). Reduced eapflkry plugging by aeutrophik with relative
preservation of endothelial cell structure was observed in Hound .
treated animals
. Infusion of Fluosd produced a marked transient
decrease In peripheral nentrophit and platelet counts in both
tschemk and nonischemk dogs and was mandated week a sigdf-
-or reduction In total hemdytie mmpkment
levels
. Studies of
neutrophg function ex vivo revealed a reduction in chemotaxis and
lysozyme dekeaaolalion after infusion or Fhlosd. In vibe taped
meats showed that Flannel produced a rapid and sustained
activation of aealrophlk determined by nlpervxide aedon preduw-
lion .
These data demonulrate that low dose intravenous, Flannel
produces a sustained reduction in infarct six in the canine model.
The beneficial effect may be is part due to the suppreoalen d
various tleutrophfl functions in the rpefused mymyrdfam sub-
sequent to peripheral actvation by
Fluman . Such Interventions;
may offer a nova therapy to ralnnoe myocardial savage by
sequestration of circulating nsatduphils dining the critical early
reperfusion peeled .
/J Am Colt Cadioi 1992,19:205-I6)
initiates the reparative process by degrading the necrotic
myocytes 121 . Regional myocardial kehemia of ?40 min
followed by reperfusion results in an accelerated and en-
hanced neutraphil influx (3-5). This exaggerated inflamma-
tory response has been postulated to have detrimental ef-
fects on the reperfused myocardium by indiscriminately
damaging potentially viable myocardial and endothelial
cells-so-called myocardial reperfusion injury (6-8).
Perfluorochemicals are substances with a small particle
size . low viscosity and high oxygen-carrying capacity . We
rreviously demonstrated (9) .hat intravenous infusion of a large
dose of the perfluerachemical Fluosol significantly reduced
infarct size determined 24 h after repcrfitsion . Reduced neutro-
phil accumulation was observed in reperfused tissue in Fluo-
sol-treated dogs and ex vivo studies showed suppression of
various neutnrphil fancticus. These findings suggest that the
0735-1097x92 $5 .50
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enhanced myocardial salvage with Fluusol might in purl be
accounted for by its effects on neutrophils .
A number of potential concerns need to be addressed
before extending this approach as well as extrapolating these
findings to humans . First. the relatively large dose utilized
previously would result in volume overload in patients with
evolving myocardial infarction . Therefore. it would be es-
sential to determine if clinically tolerable doses would retail
in a similar protective effect . Second . it would be important
to show that the beneficial
effects of Fluosol persisted
beyond the time point previously examined because it is
conceivable that Fluosol delayed the onset of irreversible
myneyle necrosis rather than resulting in a sustained reduc-
tion in reperfusiurl injury, Finally . Fluosol infusion in the
canine model is invariably associated with a marked anaphy-
lactoid reaction associated with transient severe hypolcn-
sien (10) . As this reaction is unusual in humans, it would be
important to determine its origin and whether it alters
neulrophil function, which may contribute to the myocardial
salvage (11,12) . An additional goal of the study was to
elucidate the mechanism or mechanisms of Fluosol on
neutrophil function.
The current study was therefore performed to investigate
the effects of a clinically relevant dose of intravenous
perfluorochemicul on infarct size in a canine model subjected
to 90 min of regional ischemia and 72 h of repeffusion . The
mechanism of the hemodynamic effect of perfluorochemical
and its relation to neutrophil function were also studied
utilizing both in in vivo, independent of myocardial isch-
omja, and in in vitro experiments .
Methods
Infarct Study
Surgical procedure, Mongrel dogs of eittter gender weigh-
ing 1. to 28 kg were quarantined for 2 weeks to exclude
common canine diseases . Approximately I week before
coronary occlusion,alefithoracotom ; was performed under
general anesthesia with sodium pentoba that 130 mglkg body
weight) . The heart was exposed and a st .'gical monofllament
ligature was placed around the tell anterior descending
artery proximal to the first diagonal branch and enclosed in
a polyethylene tube . A Silastic catheter was inserted into the
left atrial appendage and filled with heparin
. Both the left
anterior descending artery snare and the left atrial line were
buried in a subcutaneous pouch, the pericardium was loosely
approximated and the thorax closed . After administration of
one dose of Comhiotic (penicillin and dihydrostrepromyein)i
the dogs were allowed to recover .
Experimental protocol (Fig
. 1) . The dogs were reanesthe-
tized with sodium pentobarbital, inlubated and mechanically
ventilated with room air to maintain arterial blood gases
within the phy_dologic range . Intravenous diazepam (mean
dose 5
nag/dog)
ind morphine sulfate (mean dose 5 mg/dog)
were administered periodically throughout the protocol as
tAC-C ve, 17. Nn, I
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Pleura 1 . Experimental protocol for the infarct study, Dogs under-
wwa g0 min of ieil anterior descending artery occlusion and 72 h of
reperfusion. The time of Fluosot or Ringers lactate tRLI infusion is
shown by the sand one
. Ilemodyaamic measurements were obtained
at haseline. at I h of occlusion aid afar 1, 2, 3 and 72 h of
reperfusion, Regional myocardial blood floc was measured at
bowline. I h of occlusion and at I . 2 and 3 h of repertuston .
Neunuphil function was determined at baseline and at 1 .3 and 24 h
u! repedusion. Neutrophil and platelet counts were obtained at
haseline.jost before reperfusion and at 0 .25, 0.5, 2, 3 and 24 h after
repcrfcsiun. Contrast veotricatography was performed at baseline .
at 1 h of occlusion aad al 3 and 72 h of reperfusion- Selective
coronary nngiogmphy was performed at baseline, just before reper-
fusion and at 3 and 72 h ofreperfusioa. Histopailiologic examination
was performed 72 h after reperfusion-
required for supplemental anesthesia . Utilizing sterile tech-
niques . both femoral arteries and the right femoral vein were
exposed and each camadated with a 7F catheter sheath
(Cordis)
. A 7F Gensini catheter (USCI) was positioned with
its distal end in the proximal inferior vents cava for the
infusion of Ringer's lactate solution
or Fluosol . A 7F pigtail
catheter was placed in the distal aorta and utilized for
monitoring mean and phasic systemic arterial pressure and
left ventricular end-diastolic pressure . Electrocardiographic
(ECO) leads 1. oVF and aVL were monitored continuously
throughout the protocol (model VR-12, Electronics for Med-
icine) . The left anterior descending artery snare and left
atrial line were retrieved from the subcutaneous pocket .
Before the protocol was initiated . the dogs were randomly
assigned to Ringer's lactate solution (controll or Fluosol
(treatment) groups . Baseline Ilemodynamic measurements
were then obtained .
Regiortnf myocardial hlood ft- was determined with
serial injection of ISymr microspheres labeled with iodine-
125, cerium-141 . chromium-51 . strontium-g5, niobium-45
and scandium-46 (3M Company), respectively, at approxi-
mately 2 x 10 microspheresl5 ml into the left atria) line,
followed by a 10-mi saline solution flush
. Reference samples
were withdrawn from the left femoral artery through the
Cordis sheath at a rate of 7.85 mt1min to allow calculation of
myocardial blood flow. Selective injection of the left coro-
nary artery with a modified ludkins catheter confirmed
patency of the left anterior descending artery . Single-plane
left ventriculogaphy in the right anterior oblique projection
with S to 10 ml of meglumine diatrizoate (Renogafm-76)
injected over I s through a power injector was performed to
assess global and regional ventricular function . The dogs
received two to three 5-ml test doses of either Ringer's
JACC VM . 19. No . I
Jarmory FA2 .25'-r9
lactate solution or Fluosol intravenously before the study .
Only the initial test dose of Fluosol resulted in transient
severe hypatensian a1`5 to 10 min duration in all dogs . After
slahiliratinn
. a bolus injection of lidocaine was administered
intravenously 43 mgikg followed by a ntaintenaace infusion
or 0
.12 mgikg per min) . Occlusion of the left anterior
descending artery was achieved over 3 to 5 min and main-
rained for 90 min. Hemodynamie measurements, left ven-
triculography and regional myocardial blood flow determi-
nation: txer° repeated after 60 min of xclusitm .
Fluosol 115 mlfkg)IAlpha Therapeutics Corp_ I or Ringer's
lactate solution (I5 mllkg) was administered through the
Gensini catheter positioned in the proximal in€erior vena
eova by a Harvard pump: the infusion began 11) min before
reperfusion and ended 30 min after repcdusion . dodo control
and Fluosol•Ifeated dogs were ventilated with 1007 oxygen
to maintain partial pressure of oxygen >400 mm
Hg .
com-
mencing
at the lime or infusion and continuing for the t st 3 h
of reperfusion. After confirmation of total left anletior de-
scending artery occlusion by selective coronary ongiogra-
phy, the snare was gradually released over approximately
3 min . Reperfusion was confirmed by repeal angiography
and microsphere blood flow. Serial hemodynamic measure-
ments and regional blood flow were determined at
1 . 2 and
3 h after reperfusion . After a left veniriculogram was ob-
tained 3 h after reperfusion . the snare and left aerial line were
reimbedded into the subcutaneous pocket and the dogs
weaned from the ventilator. administered antibiotic agents
and allowed to recover .
After 72 h of reperfiesion. the dogs were carefully ream
esthetized with pentobarbital . Hemodynamic me- . ,urements
and left ventrlculography were performccd and patency of the
left anterior descending artery was confirmed by selective
coronary arteriographp . The left thorax was opened and the
coronary snare was tightened under direct vision . Monaslral
blue dye (Do Pont) at a dose of I mg/kg was injected into the
ascending aorta through a pigtail catheter within 60 s after
occluding the vessel . After administration ofa lethal dose of
pentobarbital and potassium chloride. the heart was rapidly
explanted and rinsed with tap water to prevent counterstain-
ing.
Analysts of area at risk and necrosis . The heart was
sectioned into 6 1-cm segments parallel to the atrioventric-
ular groove from apex to base and photographed with
Ektachrome (Kodakl far later determination of the area at
risk (unstained by Monaslral blue dye), The slices nut
utiized for blood flow !slices I, 3 . 5 and 6) were then
dehydrated and embedded in paraffin (with the slice facing
the base to be
used as the cutting surface) utilizing the
method of Reimer and Jennings 1131 . Microscopic sections,
7 jam thick, were then cut Orion the basal end of each slice
.and stained with hematoxylia-eosin and Mallory's t :ichrome
stains . The area at risk and area of necrosis (stained purple
by Mallory's stain) were then determined by computerized
planimetry of magnified tracings (x 51 drawn by an observer
unaware of the treatment groups. The ratio of the infarcted
FORMAN ET AL .
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area to area at risk for each heart was calculated by a method
previously described (14) .
Analysis of ventreular function . Serial global and re-
gional ventricular function were measured by digitization of
end-diastolic and cud-systolic angiographic frames . left
ventricular ejection fraction was calculated by Simpson's
rule . Regional wall motion was assessed with a radial short-
ening method with use of customized software as previously
described and validated in our laboratory (14),
I)etermtna?ivnofveg4nalmynrcardlalblood flow
. Mvocar
dial samples for determination of regional blood flow were
obtained from the second and fourth transverse myocardial
sections . Tissn- from the endocardium, mid-myocardium
and epicardium (0,15 to 0 .55 g) in the nonischemic tutor
(posterior wall) and central and lateral regions of the isch-
emic zone )unstained by Monaslral blue dye) were utilized .
These samples and arterial reference samples were counted
far 5 min in a multichannel autogamma scintillation spec-
trometer (model 59x6, Packard Instrument) . Background
contamination and overlapping radioactivity from other iso-
topes were accounted for using a matrix correction method
1Compusphere Software, Packard Instrument)and corrected
for microsphere loss and tissue edema (15,16)
. Myocardial
blood flow was calculated in milliliters per minute )>,r
.-gram
wet weight as previously described in our laboratory (14) .
Light mcroseopy . The first and third slices (numbered
from apex to base) were stained with hetnatoxylin-eosin and
examined by light microscopy in alt dogs in a blinded
manner . Variables analyzed included the degree of neutro-
phil (intravascular and interstitial) and macrophage infiltra-
tion, extent of hemorrhage, patchiness of the infarct and
degree of contraction band necrosis . An average of 20 high
power held' (x400) per slide were semiquantitated with use
of a scoring system o€ 0 to 4+ as previously described (I7) .
Electron microneupy. Myocardial biopsy samples were
taken within 60 s of death from the central ischemic zone
(anterior wall) and the nonischemic cone (posterior wall) and
divided into endocardial and epicardial halves, The tissue
was cut into t-mm' pieces and fixed in 3% buffered glutaral-
dehyde for transmission electron microscopy . Thirty-two
specimen, were examined from eight randomly selected
dogs (Pour given Fluosol and four in the control group) . After
fixation, the tissue was transferred to (% osmium tetroxide
in 0 .1-M eacodylate
buffer,
dehydrated and embedded in
Epon . Semithin sections were cut, stained with toluidine
blue and examined by light microscopy . The artifact-free
areas with the most capillaries were selected for ultrathin
section tatting, stained with umnyl acetate lead citrate and
examined wah a Zeiss 109 ]OF electron microscope .
Neurrophil F'onction
Siudies
The effects of Fivosol on neutrophil counts and function
were examined in both the regional ischemic model and in
nonischemic dogs .
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Tank 1 . Hemudynamic Measurements in II Control and 10 Fluosol-Treated Dogs
Dogs undergoiung regional ischemia. Serial blood samples
were obtained from the inferior vena cam for venous leuko-
cyte and platelet counts in dogs undergoing coronary occlu-
son and reperfusion (Fig . I). Leukocyte and
platelet counts
were quantitated by the Coulter counter method . Absolute
nentrophil counts were obtained by examining a peripheral
smear. Ex vivo neutrophil analysis of chemolaxis
and lyre
zyme release was performed on heparinized blood samples
drawn from the animal at baseline and at 1, 3 and 24 h after
reperfusion
. Neutrophils were isolated by 60-min gravity
sedimentation as previously described (9). Neutroplnl via-
bility was studied try Irypan blue dye exclusion and lactate
dehydroieoase (LDH) release (181. Chemotaxis was as-
sessed utilizing zymesan-activated ,lasma and lysozyme
release with both zymvsan and f-methionyl-leucyl-phenyl-
alanine (F'MLP) as previously described (9) .
Nonlschenae dogs. Because the effects of Fluosol on
neutrophils could be modified in the setting of ischemia and
reperfasion, five dogs that did not undergo coronary occlu-
sion were also studied . The animals were anesthetized and
ventilated as previously described . The femoral vessels were
cannulated for hemodynamic measurements, blood sampling
and drug infusion. Baseline hemodynamic data . total com-
plement, neutrophil and platelet counts and 30 cc of heparin-
ized plasma for lysozyme determination were obtained, The
dogs then received test doses (3
± 1) of 5 ml of Fluosol
intravenously until a hemodynamic response was no longer
elicited
. Repeat blood samples were then obtained . After the
dogs were placed on 100% oxygen, Fluosol was infused
over
60 min into the inferior vena nova in a manner identical to
that of the infarction protocol . Hemodynamic measurements
and blood samples for neutrophil and platelet counts and
total complement levels were obtained 30 min after the start
of infusion, at the end of infusion and at I and 3 h after
completion .
to vitro superoxide release . Canine neutrophits were iso-
lated as previously described
(9) . Superoxide anion produc-
lion was assessed by the reduction of ferricytochrome
C
with use of 2 x 10
6 neutrophilslml . Cells were incubated for
2, 5, 15, 30 and 60 min with buffer or Fluosol (50% concen-
tration) in the presence or absence of superoxide dismutase
as previously described t9) . Reduced cytochrome C reduce
lion was measured by spectraphatomelry, at 550 W.
IACL Vol 19. No. I
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LVEDP = left remrculm =ddia0ofs prewere ; Occ = cum- ereir ion
; Roe-pr-re product = bran ale x synnac preswreni0; Rep =
reperrusion .
Statistical analyss . Results over defined time points for
hemodynamic variables, regional myocardial blood flow and
ventricular function were analyzed with a two-factor analy-
sis of variance in which one factor was treatment and the
other time . U a statistically significant interaction between
treatment and time was ohtainr' . further examination of the
difference between groups was conducted using a two-tailed
unpaired Student's a test. For analysis of light microscopy
data, the results from multiple samples within the same dog
were averaged before the r test was performed. The null
hypothesis was rejected at the
5% level. All data were
expressed as mean values
y
SEM .
Remllrt
Injarrt study
Study dogs, Exclusion criteria were established before
the start of the study. These occluded intractable ventricular
arrhythmias, failure to survive for 72 h after rcperfusiou and
nbsence of adequate myocardial ischemia. The latter was
defined as failure to develop akinesia air dyskinesia on
ventriculography during coronary occlusion, area at risk
volume <15% of the left ventricle and transmural collateral
blood flow in the ischemic bed >0 .5 mtrmin per g.. One
control dog died approximately 28 h after repcrfesion,
probably from an arrhythmia
. Ten animals (four control and
six Fluosol-treated dogs) underwent successful cardiover-
sion . Twenty-one dogs completed the protocol and were
included in the final analysis (I I control and 10 Fluosol-
treated dogs).
LRboralory and hemodynamic measurements (Table Ill.
No significant differences in serial pH were noted between
the two groups throughout the protocol (data not shown).
Arterial oxygen pressure values were similar
in both groups
a1 baseline (118 ± I I [control] vs. 95 ± 14 ours, Hg [Floosoll,
p = NS) and during the 1st 3 h of repeTfusion when
supplemental oxygen was administered (422 ± 34 [control]
vs. 442 ' 35 mm Hg [Fluosol], p = NS) . The flunrecrit
measured I h after reperfus(on in four dogs ranged
front 25
to 3% . Heart race, mean arterial pressure and rate-psscue
product were
similar
in both groups throughout the protocol.
Fluosol-treated animals tended to have a lower left ventrie-
Baseline I-hOcc Rep hh Rep 2 .h Rep 3 .h pep 12-h Rep
Hear ale Ibe015laiin)
Caaval
122 a 6 .5 114 ± 16 114 e7 ?19±10 .4 176-8.5 136±1 .4 142'5.6
Florid 177 t k
119 ± 6.2 Im-6.4 11916.5 126%7.4 137 6.'-9 141_5.7
Mean arterial presser Faun Hgl Cwnral 121 14 8 176 ± 6.1 1e ±64
120'14 .2 120-5-3 1A`-5 .2 112±3,6
Fluasd 119 = 6 116 x 2 .6 125 a 4.7
122 ± 7
.4 175 ± 5.9 1
.5 x 6
.4 115 _ 5
.9
It-p- product Coma) 17.3 ± 1 .7 167 ± 1 .1 16.4_I.1 17_0 ±1 .7 16 .0±0.9 19 .4_0.7 19.5=06
Florid It.] ± 1 164z 1 15 .4_0.7 16.6 .1 .4 17 .7±1.6 20 .2±1 .6 201±0.9
LVEDP Imm Hg)
Cuetrol 6.4 `- 09 N 4 ± 1 .7 21 .3 .2.7 14.4!1 .3 12 .1.3 11.4±1 .6 17.6x2.!
Florid 6.7 ± 1,2 16.9 x 3 21 .4e5.4 13.4sIA 11 .9%1.7 10 .1!1 .6 5.3a1 .1
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Fgare 2 . Top, Effect of Fluosol ao infarct size (AN) expressed as a
percent of the area at risk (AR) and the lc--- :crarisle The area
at risk was similar in the two groups
. Intravenous adm inislation of
Fluosol significantly reduced infarct size . Bottom, Histograms illus-
trating the e0'ect of treatment in dogs with severe isdionsia (tress .
mural flow c0 .1 mUmin per g) or moderate ischemia (transmaral
flow >0.1 mhmin per gi. Fluosol significantly reduced infarct sire
nrcspoctive of the acvcrity of ischemia .
ularead-dia..Iolic pressure 72 h after rcpcrfusion, although
this difference did not reach statistical significance (p =
alas
.
Infard size (Fig, 2). Left vCnlricutar weight was similar in
both groups (data not shown) . The area at risk expressed as
a percent of the left ventricle was also comparable (29.1 2:
2% [control] vs. 2,8 '- 2-6% IFluosoq, p - NS) . A highly
significant reduction in infarct size was noted in Fuosel.
treated animals both when expressed as a percent of the area
at risk (38.3 ± 4.55E Iconrol) vs . 13 .7'- 2 .7% IFluosoll. p <
O.ool) and as a percent
of the left ventricle (11 .5 - 1 .717,
[controll vs . 4.2 m 1% IFluoso]l
. p = 0
.0011 IFg, 2 . top).
When animals were categorized according to the severity of
ischemia, arbitrarily defined as transmurat collateral bland
flow equal to, < or >0.1 mllmin per g. a similar and highly
sigaficant reduction in infarct size in Fluosol-treated dogs
was also noted (Fig . 2 . bottom). suggesting an ciect of
treatment irrespective of the degree of ischemia.
Relation of infarct sae to area at risk and collateral blood
flow (Fig . 3). The relation of infarct size expressed as a
FORMAN LT AL
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Fig- 3. linear regression analysis demonatrating this relation of
laurel slzc (AN) expressed as a percent of area artists (AR) and
transmural collateral blood flow in the central isch atic zanu nor •
maimed to baseline values . There was a significant correlation
between these variables (r - -0.63, p - 03102). A significant
difference in the Y intercept srggesls that Fluosol reduced infarct
s,zc a rep pearve d collateral blood flow.
pererrst .i' the area at risk and transmural collateral blood
flow, an important predictor of infarct size, is depicted for
both groups in Figure 3 . A significant correlation assessed by
linear regression analysis was exhibited between hese var-
iables utilizing both treated and control dogs (r = -0.63, p =
0 .0112). Although the slopes of the regression lines for each
group were not significantly different, the Fluosol-treated
dogs demonstrated a significant and favorable shift in the Y
Figured . Effect of Flaosnlen radial sbartoning tithe itchennic cone
Itop) and global left ventricular ejection fraction (batl•ml . A signil'
i .aol improvements region! function was observed in Fluosol'
treated animals 72 h alter repedusiom. BASE = baselitk ; OCC =
coronary occlusion; 3 and 72 HR - land 72 h after reperfusion.
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Figare S. Serial regional myocardial blood flow in the rv--,chcmic
(posterior wall), central ischemic and late! ;,them e. There
was significantly greater rcectivc hyperemia immediately after
reperfusion in Fauns .^! .treated dogs . A progressive decrease in flow
in thr ;.^:n two-thirds of the myocardium is noted in control dogs
during the first 3 h of reperfusion compatible with the "no re now
phenomenon ." Note tha it 3 h after reperfusion . blood flow in the
endoeardial and mid-my( udial regions was significantly increased
in the treated group cc : pared with the control group and was
similar to baseline value,
axis intercept comp; r d with control dogs (48 .1 ± 6.2%
[control] vs. 23 `_ 4:3'i 'Fluosol], p = 0 .04), which suggests
an effect of treatment ,
.-respective of collateral blood flow .
Global and regional auricular function (Fig
. 4). Baseline
regional wall motion w,.s uniform and comparable in both
groups and a similar de- ve of anteroapical dyskinesia was
noted 60 min after
corn - ary occlusion (-3 .7 ± 1 .7% [con-
trol] vs . -2 .5 ± 1 .3% -Fluosol], p = NS). A si3nificant
improvement in regional , rail motion was noted both at 3 and
72 h after reperfusion in -he treated group (72 h 5
.5 ` 2%
[Control] vs . 18 .4 ± 2.3% ]Fluosol], p < 0.001) . No signifi-
cant differences in gloL l ejection fraction were noted
throughout the protocol .
Myocardial blood flow (Fig . 5). Regional myocardial
blood flow in the control, central and lateral ischemic zones
was similar in both groups at baseline study . A marked and
comparable reduction :: : I
.tn
.,Jd flow in the inner two-thirds of
myocardium of the central
:schemic zone was noted after
60 min of left anteria : descending artery occlusion in both
groups (endocardium: 0 .05 t 0.03 (control] vs . 0.08
0.02 mlmin per g IFluosoll, p = NS; mid-myecardium ; 0 .66
s 0.02 (control] vs . 0.10 ± 0
.02 ml/min per g (Fluosoi], p
NS) . Fluosol-treated animals exhibited greater reactive hy-
peremia immediately after reperfusion in both the central
and lateral ischemic zones . A progressive reduction in flow
JACC Yd. 19, No. I
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in the endocardial and mid-myocardial regions was observed
in control dogs during the 1st 3 h of reperfusion indicative of
the 'no reflow phenomenon ." In contrast, blood flow 3 h
after reperfusion was similar to baseline values in Fluosol-
treated dogs and was significantly greater than in the control
group. Blood flow in the nonischemic zone was unchanged
throughout the protocol and similar in both groups .
Histology (Fig. 6).
Macroscopically, control dogs mani-
fested more often a confluent infarct that extended to the
mid-myocardium and was invariably hemorrhagic . in con-
trast, the infarcr in the treated group was patchier, confined
to endocardium and rarely contained hemorrhage. Ran-
domly selected biopsy specimens from all the dogs were
examined by light microscopy
. Control dogs demonstrated
significantly greater hemorrhage (p = 0 .03), contraction
hands (p = 0.02) and confluence of infarct (p = 0 .04)
compared with Fluosot-treated dogs . Because the ischemic
bed was reperfused for 72 h before death, acute inflamma-
tory cells were seen only occasionally in both groups.
Electron mier,seopy (Fig . 7 aad S) . Ultrastroctural
changes in the ischemic endocardium in control and treated
groups showed prominent changes of rcveraib[e and iire-
versibie injury (Fig . 7). Myocyte blebs with and without
disruption of the plasmalcmma, mitochondrial swelling with
disrupted crislae and amorphous matrix densities were fre-
quently observed
. Myocytes in the sobepicardial zones
rarely showed irreversible injury . The mierovasculature
showed prominent endothelial injury in control dogs, with
moderate to severe swelling and marked reduction in the
number of pinocytotic vessels . Membrane-bound vesicles,
cytoplasmic protrusions, red cell stacking, fibrin deposition
and capillary disruption were frequently seen. 1n contrast,
the Fluosol-treated dogs showed much lass injury, with only
mild to moderate swelling of endothelial cells . A mild
decrease in pinocytotic vesicles and occasional membrart-
tACC Vol . 19, No. I
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Figure 6. Qualitahoe histologic assess •
meal of acute inflammatory cell lintcrnti-
tial and intravascu!ar) and macrophage in-
filtration (A) and severity of contraction
band necrosis and myocardial hemorrhage
and patchiness of the infarct in control
dogs (white burst and Fwoso!-treated dug,
(black bus') . (RI. The sertieal oxu repre-
sents the number of dogs showing change .
The hortzomat axis represents the degree
of change from 0 to 4+ (17)
.
bound bodies were present . with infrequent led colt stacking_
and fibrin deposition. Rarely. interstitial cells showed the
presence of perfluorocarbon particles . Electron microscopic
examination of circulating neutrophils demonstrated perflu-
orocarbon particles at 3 and 24 h after reperfusion within the
cytoplasm, with an overall decrease in the secondary gran-
ules and the formation of phagosomes (Fig . g).
Neutrophil Function Study
Regional ischemic study (Fig
. 9 and 10). Venous neutro.
phil counts were similar in hoth groups at baseline study and
after I h of occlusion. Just before repetfu •s ion, a significant
reduction was observed in Fluosol-treotcd dogs that per-
sisted during the Ist 2 h of reperfusirm. suggesting the
decrease was independent of reperfusion . Although neutro-
phil counts increased progressively during the Ist 24 h of
IIEUTROPRIL
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rey farina they Ircded to be lower in treated dogs . Platelet
counts showed similar trends in the Fluosol-treated dogs
during the early reperiasion period (Fig . 9 . bottom) .
figure 10. top shows the effect on neutrophil chemotaxis
ex giro in both groups . Control dogs demonstrated a pro-
gressive increase in the ability of neutrophils to migrate to
zymosan-activated serum. In contrast, neutrophils from
treated dogs manifested a significant suppression ofehemo-
taxis . A significant ruuction in lysozyme release during the
I st 3 h of reperfusion was also observed in the Fluosol group
compared with the control group (Fig. 10, bottom) .
Nnnicchemic study (Fig. I I and 12). Figure I I shows that
the test dose of Fluosol produced a marked transient by-
potensivc response in control dogs similar to that ohsered
in dogs undergoing ischemia . This was associated with a
transient significant decrease in venous neutrophit and plate-
let counts and a decrease in total hemolytic complement .
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Figure 7, Electron photomicrographs showing capillary endothelial
changes in control (A and B) and perfluocachemical-treated IC and
U) animals
. A, The endedlelial cell is markedly swollen with a
decrease in pinocytotic vesicles and the lumen is obstructed by red
cells IRI. B . Endothelial cell swelling with membrane-bound vesicles
and protrusions larruwheedlk with red cell slacking causing lumen
obstrudioc . C, Meld eadothelial cell swelling wilk sane decrease in
pinoeytotic -icles.'Ihe capillary lumen is patent . 0, Minimal
endothelial ~dl pruyecfluns larrowhead) with ocwsiawl rust ells (R)
in the lumen .
The time course of the direct activation of a 50% concentra-
tion of Fluosol on superoxide anion release on canine
neutrophils in vitro is shown in Figure 12 . Neutrophil
activation was observed with 2 min of exposure and a
continual increase was observed up to W min .
Discussion
Perfluorochemicals and infarct size reduction, Perflu-
orocarbons were initially developed as artificial bitwd sub-
stitutes because of their ability to carry oxygen at high
partial pressures . We have previously demonstrated that
intravenous administration of large doses of the perfluoro-
JACC Yd . 19 . :vo. 1
tar wry rme ton-It
chemical Fluosol significantly reduced infarct size 24 h after
rcpcrfusion and this decrease was associated with decreased
polymorphonuclear cell infiltration into the reperfused bed
(9),
Several important issues needed to be addressed before
these data can be extrapolated to the clinical situation . First,
the large dose of Fluosol utilized in our prior study (91 would
result in volume overload in patieals with acute myts ardial
infarction (1,750 vs . 1,050 ml in the present study for a 70-kg
human). Second, the dogs were kllled at 24 h
. It is now
recognized that 24-h evaluation of pharmacologic agents on
infarct size reduction may he irmpprnpriare because these
agents may only delay the necrotic process 115,19-21) . To
determine if Fluosol resulted
in
a sustained reduction in
infarct size, the dogs
in
this studs were killed at 72 h because
infarct size is complete at this time . Finally, the exact
mechanisms for the protective eficci of the drug on myocar-
dial reperfusion injury still need to be elucidated .
Current study, Our findings demonstrate that intrave-
nous infusion al :-reiatively low dose of the perfluorochem-
ical Fluosol (15 mbkg) during the early reperfusion period
results in a substantial and sustained reduction in infarct size
at 72 it and improvement in regional ventricular function in
JACC Vat. 19 . No . I
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Figure a. Electron uicrugraphs of cheulating neutrophds in a am-
teal dog (A) and in a perfuorochemical-treated dog 111) 24 h after
reperhasion . Perfluorocarbon particles tarrou,l are seen in the
Fluosol-Irealed dog with a decrease in secondary grannies
.
the canine made] of regional ischemia . It is unlikely that
preconditioning could account for infarct size reduction
because severe hypertension was transient (<5 min) and did
not result in ECG evidence of ischemia (221. Fluosol-treated
dogs manifested both an enhanced hyperemic response and
significantly higher blood flow in the inner two-thirds of the
myocardium in the isehemic zone after 3 h of reperfusiun. In
dogs during the early reperfiasion period was compatible
with the no reflow phenomenon . UIIrastructural analysis
confirmed that microvascular injury was reduced in the
treated dogs . Endothelial cell swelling, memhraee-bound
vesicles and Icutrophil plugging of the capillary lumens were
more frequently observed in control dogs,
whereas
treated
dogs showed relative preservation of the microvasculature is
the reprefused bed . These data therefore confirm and extend
our previous observations in which a large dose of Fluosol
reduced infarct size measured histochemically 24 h after
reperfusion (9) . Therefore, the administration of a clinically
feasible dose provided sustained benefit an myocardial sal-
vage that was associated with an improvement in regional
venlricnlar function_
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Figure 9. Top, Time worm of venous neutrophd counts during The
isehemic protocol, Slid fine indicates the rim of Fluosol a
Ringer's lactate infusion. Fluosol resulted in a transient leukopenia
during the first 90 min of reperfusion . A progcssive but blunted
increase in counts was seen in treated dogs for up to 24 h of
reperfusion. Ilatton, Time course of peripheral platdet vaunts
during the isehemic protocol . A
similar and transient tnrombocyro-
penis was also observed in Fluosol-treated dogs undergoing myo-
cardial
schemia and reperfusion.
Rule of ntn(etpltda in myocardial irchemidrepeefusial .
Although neutrophils are a vital component of the acute
inflammatory response, a considerable body of evidence
suggests that these cells may have detrimental effects after
reperfusion of the previously isehemic myocardium
(3 .8 .9.23,241. This hypothesis is supported by the observa-
tion that the administration of numerous anti-inflammatory
agents or
antibodies
that reduce neutrophil adherence or
produce a systemic neutropenia all significantly reduced
infarct size in the experimental model 424-27) . In our previ-
ous study
(F), we showed that administration o( a large dose
of the perfiooroch!mical Fluosol suppressed various neutro-
phil functions studied as vivo I h after reperfusian. The time
course of these effects and the exact mechanism of this
apparent nemrophil suppression are unknown .
Potential Mechanisms gfelction of Fluosol
Effects a cumpkrawl . Fluosol administration in both
isehemic and nnni9ehemic dogs resulted in a modest rran-
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Figen 10. Top, Effect of Fluosol and Ringer's lactate infusion an
neutrophil chemutaais ex vivo In dogs undergoing myocardial isch-
emla at baseline and at 1, 3 and 24 h alter repetfasion (KEPI
. Note
a progressive increase in the ability of neutrophils to migrate to the
patent chamoatlroclam zymossn during the Ist 24 h of reperfttsiwt
in control animals. Results have been normalized
. Bottom, Results
of numtalized neutrophil €ysozyme degranulation at baseline (B) and
at I, 3 and 24 h of reperfusion (REP) . Cells were slimulatL.' with
f methionyltcucyl-phenylalanine (FMLP) or opsonized zymosan
(OZ)- Significantly decreased degranulation was seen with op
sonized zymosan at I and 3 h after reperfusion in Fluosol-treated
emnpared with control dogs. Also note that control dogs manifested
enhanced release compared with beset ac, particularly with f-
melhionyl-loucyl-pbeny€alanine
; Ibis difference was significant at 1 b
after reperflasion .
sient reduction in peripheral neutrophil and platelet counts .
In the nonischcmic group, this was associated with a brief
decrease in systolic blood pressure and total circulating
complement levels, These observations suggest that in the
canine model, systemic complement aclivation by Fluosol is
responsible for the transient anaphylacloid reaction resulting
in hypotension, neutropenia and thromboeytopenia .
Cobra venom factor, which results in a significant and
sustained decrease (°-g0%o fur up to 24 h) in circulating total
complement levels, reduces myocardial necrosisassessed by
cardiac creatine kinase levels in a permanent acelusian
model
(2R).
The transient modest decrease in complement
levels (returning to 70% of baseline value in <3 h) is unlikely
to account for the striking reduction in infarct size observed
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Fwwe 11. Effect of FTaosut in five dogs that did not undergo
coronary occlusion. The test dose (simgle barm )O mill resulted in
transient hypotensinn, which was associated with a significant
deemase in oeutrophil, platelet and total complement (Cft50) tevets .
The solid ha indicates the time of Fluosol infusion.
in the ischemic group. Although antibody-mediated persist-
ent neutrophil depletion significantly reduces infarct size,
the transient modest decrease in circulating neutrephils only
during the 1st 2 h of reperfusion would not produce the
sustained beneficial effects on myocardial salvage observed
in this study (27). Furthermore . a previous study (21) dean .
onstrated that administration of iloprost . an agent that sup-
JACC Vat. 19. No- I
January W2:205-16
Flnure 12. Effect of a
SE,
concentration of Ftuo.ul on upemxide
anion release on unstimulated canine neutrophils 1PMNs1S heie the
progressive increase in superoxidr release for np to fA Ian of
incubation with the dmg,
presses neutrophil functions, required a 4li-h infusion period
to provide sustained benefit .
Effects on neutrophils . In the current study . built chernu-
taxis and lysozyme release were suppressed in the Fluosol
group for 9224 h when studies were performed ex vivo .
These findings confirm and extend our previous study f9) in
which a larger dose of intravenous Fluosol suppressed
various neutrophil functions I h after rperfusion. Because
analysis of ex vivo neutrophil functions in this and our
previous study (9) were performed after a period of exposure
of the cells to Fluosol both in vivo and in vitro, apparent
"suppression" would be found if the cells bad undergone
prior activation. To address this hypothesis, in vitro studies
were performed to assess the time course of neutrophil
superoxide anion release by Fluosol on unstimt.dated canine
cells . These investigations showed that Fluosol produced a
direct time-dependent activation of neutrophil free radical
production that began within 5 min of exposure to the dmg .
In the rabbit model and in humans . although complement
activation rarely occurs . enhanced myocardial salvage and
improved ventricular function were observed with Fluosol
(29,30) . These observations support the concept that an
important mechanism of action of Floasoi oa infarct size
reduction is persistent direct activation of circulating neu-
trophils .
Other potential
mechanisms
of action. Because Fluosol
was administered during the last 31) min of regional ischemia
and the dogs were ventilated with 1011% oxygen, it is
conceivable that the drug improved collateral blood flow or
altered regional metabolism before repetfusion . Although
regional blood flow was not measured during coronary
occlusion after Fluosol infusion, we
previously
showed 191
that a larger intravenous dose of the agent did not improve
regional flow measured with miernspheres . Intracorenary,
administration of oxygenated Ruosol after reperfusion sig
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nificantly reduced infarct size in the cani : a model of 24 h and
2 weeks of reperfusion (14.311 . Further sttdies are needed to
explore where oxygen delivery plays an additional role in the
protective effect of intravenous Fluosol and to determine
whether its primary beneficial effect occurs during ischemia
or reperfusion
. Or both.
PoicnlfaJ Clinical Limitations
Elect of Fltwsst an Infarct healing . Because ncntrophils
are responsible for both the demolition and early repair of
infarcted t issue. it is essential to determine the long-term
effects of Fluosol on ventricular function and infarct healing.
We previously studied 1311 the effect of Fluosol on infarct
healing and repair after a 2-creek reperfusion period in the
canine model . Ventricular function was significantly
im•
proved in treated dogs, and histologic studies showed a
pronounced infiltnaaion of perfluerochemical-laden macro-
phages with normal WOW and collagen deposition . In the
rabbit model, Flunsnl did not reduce wall thickness in the
tschemic cone or alter hydroxyproline content (29). These
studies suggest that Fluosol does not affect infara healing or
impair ventricular function in two experimental models of
rperfusiun .
Organ retention and volume worked . Another potential
adverse effect of Fluosol is the prolonged organ half-life due
to retention a; the emulsion in the reticuloendotheliat system
producing potential hepalotoxicily 1321
. This could reduce
the immune system's ability to clear
infectious agents .
However. no increased incidence of infections has been
observed in patients receiving Fluosol for anemia or during
balloon angioplasly (33,34). Finally, although the dose uti-
lized ill this study was 40% lower than that used in our
previous study and well tolerated in the canine model, rapid
administration of 1,000 ml of Fluosol to a 70-kg man could
precipitate pulmonary edema in patients with marked left
ventricular dysfunction in the selling of acute myocardial
infarction . Such patients would require careful hemody-
namic monitoring of left ventricular filling pressure during
infusion of the dose used in this study .
Implications. Timely reperfusion remains the optimal
fond of treatment in evolving myocardial infarction . The
administration op a low dose of the perlluorochendcal emul-
sion Fluosol intravenously resulted in a significant and
sustained reduction in infarct size and improvement in
ventricular function. The current study adds further support
for the rote of the nentraphil in mediating cellular injury after
myocardial t6 chemiaand reperfusion, and it suggests a novel
therapy for reducing myocardial reperfusion injury . Pharma.
colegic activation of serdrophils in the peripheral circulation
results in suppression of the cytotoxic potential of these cells
during the critical period of rpcrfusion . Equivocal results
have been demonstrated with neutrophil-adh-S ve antibodies
that limit neutrophil tocalzation in repcrfuscd ticsuc (25 .35) .
These findings suggest ebherthat such forms of therapy may
not totally remove the critical mass of neutrophils or that
21 6
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they do not alter other neutrophil functions responsible for
mediating cellular injury. Although Flunsol did not produce
as pronounced a leukopenia as is seen with neutrophil
antibody administration, the exposure of these cells to the
drug in the peripheral circulation may result in their apparent
"deactivation," thereby reducing release of potentially cy
totoxic compounds into the vasculature of the myocardium
during reperfusion.
We goxlcfully app-- the a,pert sarnaral assistanrr o1 Kathy Tuggle .
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